+36%

est. 2Y upside i

FinTechSeries A

Truemed is redefining how Americans use their healthcare dollars. We partner with leading health and wellness brands — including Peloton, Garmin, Sleep Number, and many more — to make their products eligible for HSA/FSA spending. The result: a simple, affordable way for consumers to invest in tools that actually improve their health.

Rank

#1227

Sector

Health & Wellness Fintech

Est. Liquidity

~4Y

Data Quality

Data: Low

Truemed offers high-risk, high-reward equity with an expected upside of ~36% over 2 years, driven by exceptional growth.

Last updated: July 19, 2026

Bull (25%)+140%

Revenue reaches $36.4M in 24 months; exit multiple expands to 10x (category leadership, IPO window) implying ~$364M market cap. After 20% dilution, upside ~140%.

Base (50%)+36%

Revenue reaches $36.4M; exit multiple converges to 6x (mid of comp range) implying ~$218M. After 20% dilution and preference, net upside ~36%.

Bear (25%)-66%

Revenue slows; exit multiple compresses to 3x implying ~$109M. After 1x preference ($34M), common equity value ~$75M, and 20% dilution leads to -66% return.

Est. time to liquidity~4.0 years

Preference Stack Risk

high

Funding Intensity

2430%

Total funding of $34M represents 24.3% of estimated entry valuation, meaning preferred shareholders have significant liquidation preference.

Dilution Risk

moderate

Given recent Series A and likely 2+ years of runway, additional fundraising is not imminent but plausible; 20% dilution assumed.

Secondary Liquidity

none

No secondary market activity detected; no recent tender offers or private transactions evident.

Go to Market — 4 roles

Operations — 1 role

Product & Design — 1 role

View all 6 open roles at Truemed →

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on Truemed's data — designed to show you've done your homework.

  • 1

    “How does Truemed defend against HealthEquity's direct-to-consumer HSA tools?”

  • 2

    “What is the unit economics per transaction and how does it scale?”

  • 3

    “What is the expected timeline to an IPO or acquisition, and how does that align with employee equity liquidity?”

Community

Valuation Sentiment

Our model estimates +36% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.